These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12667100)

  • 1. Targeting c-Myb expression in human disease.
    Ramsay RG; Barton AL; Gonda TJ
    Expert Opin Ther Targets; 2003 Apr; 7(2):235-48. PubMed ID: 12667100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis.
    Sarvaiya PJ; Schwartz JR; Hernandez CP; Rodriguez PC; Vedeckis WV
    Am J Hematol; 2012 Oct; 87(10):969-76. PubMed ID: 22764095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology evaluation: leukemia therapy, University of Pennsylvania.
    Orr RM
    Curr Opin Mol Ther; 1999 Jun; 1(3):399-403. PubMed ID: 11713805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of c-Myb is associated with suppression of distant metastases in colorectal carcinoma.
    Tichý M; Knopfová L; Jarkovský J; Pekarčíková L; Veverková L; Vlček P; Katolická J; Čapov I; Hermanová M; Šmarda J; Beneš P
    Tumour Biol; 2016 Aug; 37(8):10723-9. PubMed ID: 26873484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and MYB in breast cancer: potential for new therapies.
    Gonda TJ; Leo P; Ramsay RG
    Expert Opin Biol Ther; 2008 Jun; 8(6):713-7. PubMed ID: 18476782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligodeoxynucleotide directed against c-myb has anticancer activity and potentiates the antiproliferative effect of conventional anticancer drugs acting by different mechanisms in human colorectal cancer cells.
    Abaza MS; Al-Attiyah RJ; Al-Saffar AM; Al-Sawan SM; Moussa NM
    Tumour Biol; 2003; 24(5):241-57. PubMed ID: 15001837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.
    Pagnan G; Stuart DD; Pastorino F; Raffaghello L; Montaldo PG; Allen TM; Calabretta B; Ponzoni M
    J Natl Cancer Inst; 2000 Feb; 92(3):253-61. PubMed ID: 10655443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.
    Brignole C; Pagnan G; Marimpietri D; Cosimo E; Allen TM; Ponzoni M; Pastorino F
    Cancer Lett; 2003 Jul; 197(1-2):231-5. PubMed ID: 12880987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
    Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
    Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of c-myb antisense oligonucleotides to increase the sensitivity of human colon cancer cells to cisplatin.
    Funato T; Satou J; Kozawa K; Fujimaki S; Miura T; Kaku M
    Oncol Rep; 2001; 8(4):807-10. PubMed ID: 11410788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
    Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
    J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myb is required for self-renewal in a model system of early hematopoiesis.
    White JR; Weston K
    Oncogene; 2000 Feb; 19(9):1196-205. PubMed ID: 10713708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of acivicin-induced monocytoid differentiation of human myeloid leukemia cells to acivicin-induced modulation of growth factor, cytokine, and protooncogene mRNA expression.
    Weinberg JB; Mason SN
    Cancer Res; 1991 Feb; 51(4):1202-9. PubMed ID: 1997162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer.
    Sala A
    Eur J Cancer; 2005 Nov; 41(16):2479-84. PubMed ID: 16198555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Myb-dependent gene expression by the sesquiterpene lactone mexicanin-I.
    Bujnicki T; Wilczek C; Schomburg C; Feldmann F; Schlenke P; Müller-Tidow C; Schmidt TJ; Klempnauer KH
    Leukemia; 2012 Apr; 26(4):615-22. PubMed ID: 21986841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb.
    Emambokus N; Vegiopoulos A; Harman B; Jenkinson E; Anderson G; Frampton J
    EMBO J; 2003 Sep; 22(17):4478-88. PubMed ID: 12941699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-erbB2 and c-myb induce mouse oocyte maturation involving activation of maturation promoting factor.
    Zheng LP; Huang J; Zhang DL; Xu LQ; Li F; Wu L; Liu ZY; Zheng YH
    DNA Cell Biol; 2012 Feb; 31(2):164-70. PubMed ID: 21793718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of c-myb in the chicken pre B-cell line DT40.
    Appl H; Klempnauer KH
    Oncogene; 2002 May; 21(19):3076-81. PubMed ID: 12082539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the transcription factor Myb by small-molecule inhibitors.
    Uttarkar S; Frampton J; Klempnauer KH
    Exp Hematol; 2017 Mar; 47():31-35. PubMed ID: 28017646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.